1 SARS-Cov-2 Vaccine (Vero Cell) Market Overview 1.1 Product Overview and Scope of SARS-Cov-2 Vaccine (Vero Cell) 1.2 SARS-Cov-2 Vaccine (Vero Cell) Segment by Type 1.2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Whole Virus Inactivated Vaccine 1.2.3 Split Vaccine 1.2.4 Subunit Vaccine 1.2.5 Others 1.3 SARS-Cov-2 Vaccine (Vero Cell) Segment by Application 1.3.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Comparison by Application: (2021-2027) 1.3.2 Special Population 1.3.3 General Population 1.4 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Estimates and Forecasts 1.4.1 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue 2016-2027 1.4.2 Global SARS-Cov-2 Vaccine (Vero Cell) Sales 2016-2027 1.4.3 SARS-Cov-2 Vaccine (Vero Cell) Market Size by Region: 2016 Versus 2021 Versus 2027 2 SARS-Cov-2 Vaccine (Vero Cell) Market Competition by Manufacturers 2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Manufacturers (2016-2021) 2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Manufacturers (2016-2021) 2.3 Global SARS-Cov-2 Vaccine (Vero Cell) Average Price by Manufacturers (2016-2021) 2.4 Manufacturers SARS-Cov-2 Vaccine (Vero Cell) Manufacturing Sites, Area Served, Product Type 2.5 SARS-Cov-2 Vaccine (Vero Cell) Market Competitive Situation and Trends 2.5.1 SARS-Cov-2 Vaccine (Vero Cell) Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest SARS-Cov-2 Vaccine (Vero Cell) Players Market Share by Revenue 2.5.3 Global SARS-Cov-2 Vaccine (Vero Cell) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 SARS-Cov-2 Vaccine (Vero Cell) Retrospective Market Scenario by Region 3.1 Global SARS-Cov-2 Vaccine (Vero Cell) Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global SARS-Cov-2 Vaccine (Vero Cell) Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America SARS-Cov-2 Vaccine (Vero Cell) Market Facts & Figures by Country 3.3.1 North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country 3.3.2 North America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe SARS-Cov-2 Vaccine (Vero Cell) Market Facts & Figures by Country 3.4.1 Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country 3.4.2 Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Market Facts & Figures by Region 3.5.1 Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales by Region 3.5.2 Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America SARS-Cov-2 Vaccine (Vero Cell) Market Facts & Figures by Country 3.6.1 Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country 3.6.2 Latin America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.6.6 Colombia 3.7 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Market Facts & Figures by Country 3.7.1 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Country 3.7.2 Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global SARS-Cov-2 Vaccine (Vero Cell) Historic Market Analysis by Type 4.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2016-2021) 4.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Type (2016-2021) 4.3 Global SARS-Cov-2 Vaccine (Vero Cell) Price by Type (2016-2021) 5 Global SARS-Cov-2 Vaccine (Vero Cell) Historic Market Analysis by Application 5.1 Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2016-2021) 5.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Application (2016-2021) 5.3 Global SARS-Cov-2 Vaccine (Vero Cell) Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Sinopharm 6.1.1 Sinopharm Corporation Information 6.1.2 Sinopharm Description and Business Overview 6.1.3 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio 6.1.5 Sinopharm Recent Developments/Updates 6.2 Sinovac Biotech 6.2.1 Sinovac Biotech Corporation Information 6.2.2 Sinovac Biotech Description and Business Overview 6.2.3 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio 6.2.5 Sinovac Biotech Recent Developments/Updates 6.3 BIBP 6.3.1 BIBP Corporation Information 6.3.2 BIBP Description and Business Overview 6.3.3 BIBP SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2016-2021) 6.3.4 BIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio 6.3.5 BIBP Recent Developments/Updates 6.4 IMBCAMS,China 6.4.1 IMBCAMS,China Corporation Information 6.4.2 IMBCAMS,China Description and Business Overview 6.4.3 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2016-2021) 6.4.4 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio 6.4.5 IMBCAMS,China Recent Developments/Updates 6.5 WIBP 6.5.1 WIBP Corporation Information 6.5.2 WIBP Description and Business Overview 6.5.3 WIBP SARS-Cov-2 Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2016-2021) 6.5.4 WIBP SARS-Cov-2 Vaccine (Vero Cell) Product Portfolio 6.5.5 WIBP Recent Developments/Updates 7 SARS-Cov-2 Vaccine (Vero Cell) Manufacturing Cost Analysis 7.1 SARS-Cov-2 Vaccine (Vero Cell) Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of SARS-Cov-2 Vaccine (Vero Cell) 7.4 SARS-Cov-2 Vaccine (Vero Cell) Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 SARS-Cov-2 Vaccine (Vero Cell) Distributors List 8.3 SARS-Cov-2 Vaccine (Vero Cell) Customers 9 SARS-Cov-2 Vaccine (Vero Cell) Market Dynamics 9.1 SARS-Cov-2 Vaccine (Vero Cell) Industry Trends 9.2 SARS-Cov-2 Vaccine (Vero Cell) Growth Drivers 9.3 SARS-Cov-2 Vaccine (Vero Cell) Market Challenges 9.4 SARS-Cov-2 Vaccine (Vero Cell) Market Restraints 10 Global Market Forecast 10.1 SARS-Cov-2 Vaccine (Vero Cell) Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of SARS-Cov-2 Vaccine (Vero Cell) by Type (2022-2027) 10.1.2 Global Forecasted Revenue of SARS-Cov-2 Vaccine (Vero Cell) by Type (2022-2027) 10.2 SARS-Cov-2 Vaccine (Vero Cell) Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of SARS-Cov-2 Vaccine (Vero Cell) by Application (2022-2027) 10.2.2 Global Forecasted Revenue of SARS-Cov-2 Vaccine (Vero Cell) by Application (2022-2027) 10.3 SARS-Cov-2 Vaccine (Vero Cell) Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of SARS-Cov-2 Vaccine (Vero Cell) by Region (2022-2027) 10.3.2 Global Forecasted Revenue of SARS-Cov-2 Vaccine (Vero Cell) by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units) Comparison by Application (2021-2027) Table 3. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers SARS-Cov-2 Vaccine (Vero Cell) Covered in This Study Table 5. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Manufacturers (2016-2021) Table 7. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Manufacturers (2016-2021) Table 9. Global Market SARS-Cov-2 Vaccine (Vero Cell) Average Price (US$/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers SARS-Cov-2 Vaccine (Vero Cell) Manufacturing Sites and Area Served Table 11. Manufacturers SARS-Cov-2 Vaccine (Vero Cell) Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global SARS-Cov-2 Vaccine (Vero Cell) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in SARS-Cov-2 Vaccine (Vero Cell) as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2016-2021) & (K Units) Table 16. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region (2016-2021) Table 17. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2016-2021) & (US$ Million) Table 18. North America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2016-2021) & (K Units) Table 19. North America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2016-2021) Table 20. North America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2016-2021) & (US$ Million) Table 21. North America SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2016-2021) Table 22. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2016-2021) & (K Units) Table 23. Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2016-2021) Table 24. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region (2016-2021) Table 28. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Region (2016-2021) Table 30. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2016-2021) & (K Units) Table 31. Latin America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2016-2021) Table 32. Latin America SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Country (2016-2021) Table 38. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units) by Type (2016-2021) Table 39. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Type (2016-2021) Table 40. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (Million US$) by Type (2016-2021) Table 41. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Type (2016-2021) Table 42. Global SARS-Cov-2 Vaccine (Vero Cell) Price (US$/Unit) by Type (2016-2021) Table 43. Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units) by Application (2016-2021) Table 44. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Application (2016-2021) Table 45. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (Million US$) by Application (2016-2021) Table 46. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Application (2016-2021) Table 47. Global SARS-Cov-2 Vaccine (Vero Cell) Price (US$/Unit) by Application (2016-2021) Table 48. Sinopharm Corporation Information Table 49. Sinopharm Description and Business Overview Table 50. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 51. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Product Table 52. Sinopharm Recent Developments/Updates Table 53. Sinovac Biotech Corporation Information Table 54. Sinovac Biotech Description and Business Overview Table 55. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 56. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Product Table 57. Sinovac Biotech Recent Developments/Updates Table 58. BIBP Corporation Information Table 59. BIBP Description and Business Overview Table 60. BIBP SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 61. BIBP SARS-Cov-2 Vaccine (Vero Cell) Product Table 62. BIBP Recent Developments/Updates Table 63. IMBCAMS,China Corporation Information Table 64. IMBCAMS,China Description and Business Overview Table 65. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 66. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Product Table 67. IMBCAMS,China Recent Developments/Updates Table 68. WIBP Corporation Information Table 69. WIBP Description and Business Overview Table 70. WIBP SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 71. WIBP SARS-Cov-2 Vaccine (Vero Cell) Product Table 72. WIBP Recent Developments/Updates Table 73. Production Base and Market Concentration Rate of Raw Material Table 74. Key Suppliers of Raw Materials Table 75. SARS-Cov-2 Vaccine (Vero Cell) Distributors List Table 76. SARS-Cov-2 Vaccine (Vero Cell) Customers List Table 77. SARS-Cov-2 Vaccine (Vero Cell) Market Trends Table 78. SARS-Cov-2 Vaccine (Vero Cell) Growth Drivers Table 79. SARS-Cov-2 Vaccine (Vero Cell) Market Challenges Table 80. SARS-Cov-2 Vaccine (Vero Cell) Market Restraints Table 81. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Type (2022-2027) & (K Units) Table 82. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share Forecast by Type (2022-2027) Table 83. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Type (2022-2027) & (US$ Million) Table 84. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share Forecast by Type (2022-2027) Table 85. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Application (2022-2027) & (K Units) Table 86. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share Forecast by Application (2022-2027) Table 87. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Application (2022-2027) & (US$ Million) Table 88. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share Forecast by Application (2022-2027) Table 89. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Forecast by Region (2022-2027) & (K Units) Table 90. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share Forecast by Region (2022-2027) Table 91. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Forecast by Region (2022-2027) & (US$ Million) Table 92. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share Forecast by Region (2022-2027) Table 93. Research Programs/Design for This Report Table 94. Key Data Information from Secondary Sources Table 95. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of SARS-Cov-2 Vaccine (Vero Cell) Figure 2. Global SARS-Cov-2 Vaccine (Vero Cell) Market Share by Type in 2020 & 2027 Figure 3. Whole Virus Inactivated Vaccine Product Picture Figure 4. Split Vaccine Product Picture Figure 5. Subunit Vaccine Product Picture Figure 6. Others Product Picture Figure 7. Global SARS-Cov-2 Vaccine (Vero Cell) Market Share by Application in 2020 & 2027 Figure 8. Special Population Figure 9. General Population Figure 10. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size 2016-2027 (US$ Million) Figure 12. Global SARS-Cov-2 Vaccine (Vero Cell) Sales 2016-2027 (K Units) Figure 13. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 14. SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Manufacturers in 2020 Figure 15. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Manufacturers in 2020 Figure 16. The Global 5 and 10 Largest SARS-Cov-2 Vaccine (Vero Cell) Players: Market Share by Revenue in 2020 Figure 17. SARS-Cov-2 Vaccine (Vero Cell) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 18. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region (2016-2021) Figure 19. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share by Region in 2020 Figure 20. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Region (2016-2021) Figure 21. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share by Region in 2020 Figure 22. United States SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Canada SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Germany SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. France SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. U.K. SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Italy SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Russia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. China SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Japan SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. South Korea SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. India SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Australia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. China Taiwan SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Indonesia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Thailand SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Malaysia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Mexico SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Brazil SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Argentina SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Colombia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. UAE SARS-Cov-2 Vaccine (Vero Cell) Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of SARS-Cov-2 Vaccine (Vero Cell) by Type (2016-2021) Figure 46. Sales Market Share of SARS-Cov-2 Vaccine (Vero Cell) by Application (2016-2021) Figure 47. Sales Market Share of SARS-Cov-2 Vaccine (Vero Cell) by Application in 2020 Figure 48. Revenue Share of SARS-Cov-2 Vaccine (Vero Cell) by Application (2016-2021) Figure 49. Revenue Share of SARS-Cov-2 Vaccine (Vero Cell) by Application in 2020 Figure 50. Manufacturing Cost Structure of SARS-Cov-2 Vaccine (Vero Cell) Figure 51. Manufacturing Process Analysis of SARS-Cov-2 Vaccine (Vero Cell) Figure 52. SARS-Cov-2 Vaccine (Vero Cell) Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Sinopharm Sinovac Biotech BIBP IMBCAMS,China WIBP